Table 2.
Mean ADC values (bold) ± standard deviation (min.|max.) of all tumor manifestations depending on the clinical parameters and associated groupings or the molecular status. Within the respective parameter groups, there was only a significant difference in the ADC mean values stratified according to the INRG risk group between the high-risk group and the intermediate-risk group (p = 0.02).
| Clinical Groups | n | ØADC ± SD [10−7 mm2/s] | Min.|Max. [10−7 mm2/s] | p |
|---|---|---|---|---|
| INSS stage | ||||
| 4 | 27 | 147.71 ± 60.95 | 48.84|383.33 | |
| 3 | 7 | 147.68 ± 47.58 | 76.88|295.93 | 0.6 |
| N-MYC | ||||
| positive | 11 | 138.94 ± 57.37 | 55.54|279.68 | |
| negative | 17 | 151.91 ± 61.73 | 48.84|383.33 | 0.2 |
| INRG risk group | ||||
| high-risk | 26 | 141.43 ± 59.27 | 48.84|383.33 | 0.02 |
| intermediate-risk | 8 | 169.26 ± 50.86 | 76.88|295.93 | |